Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Torrance › NPI 1467459776
Hospital

Torrance Memorial Medical Center

Torrance Memorial Medical Center was paid $17.91M by Medicaid between Jan 2018 and Dec 2024, across 210 billing codes. Its largest line is 0450, Emergency room services — 18% of everything it billed.

33Billing provider infoTORRANCE MEMORIAL MEDICAL CENTER
TORRANCE, CA 90505
33aNPI1467459776assigned 06/30/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$17.91M
24GClaims704,296
24DCodes billed210
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#130 of 410
Median peer was paid$6.90M
This provider vs. median2.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201898,298$2.08M
201984,785$1.79M
202069,366$1.58M
202175,596$1.95M
2022108,222$3.46M
2023139,408$4.25M
2024incomplete128,621$2.81M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
0450 Emergency room services 18% 77,739 68,756 $3.16M
0202U Oncology (prostate), multianalyte, gene expression profiling 10% 7,432 6,887 $1.86M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 6.7% 6,240 5,860 $1.20M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 3.6% 12,627 11,692 $639K
74177 Computed tomography, abdomen and pelvis; with contrast material 3.0% 2,833 2,736 $541K
74176 Computed tomography, abdomen and pelvis; without contrast material 2.9% 6,083 5,862 $527K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 2.7% 7,161 6,555 $487K
70450 Computed tomography, head or brain; without contrast material 2.7% 6,153 5,938 $481K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 2.6% 4,712 4,461 $464K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 2.5% 4,308 4,099 $453K
80048 Basic metabolic panel (calcium, ionized) 2.4% 39,805 35,726 $428K
J0131 Injection, acetaminophen, not otherwise specified,10 mg 2.2% 2,123 2,003 $386K
198 more codes
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 2.1% 3,240 $369K
99199 Unlisted special service, procedure or report 2.0% 10,519 $362K
99283 Emergency room visit (moderate) 1.9% 3,792 $335K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.8% 17,764 $322K
96375 Therapeutic injection; each additional sequential IV push 1.8% 11,314 $322K
J3490 Unclassified drugs 1.4% 19,690 $252K
96361 Intravenous infusion, hydration; each additional hour 1.4% 10,497 $245K
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg 1.3% 1,384 $240K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.2% 43,500 $217K
76700 Ultrasound, abdominal, real time with image documentation; complete 1.2% 3,560 $212K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1.1% 11,039 $202K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.1% 3,065 $189K
71045 Radiologic examination, chest; single view <1% 15,993 $163K
76830 Ultrasound, transvaginal <1% 2,713 $141K
71046 Radiologic examination, chest; 2 views <1% 7,356 $129K
93971 <1% 1,835 $124K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 426 $123K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 8,918 $118K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 3,485 $113K
87631 <1% 2,878 $110K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 4,258 $103K
71275 Computed tomographic angiography, chest, with contrast material <1% 774 $100K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 1,844 $96K
80076 <1% 16,526 $90K
71250 <1% 850 $88K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,823 $79K
84484 <1% 11,572 $77K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 12,285 $76K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 2,799 $74K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 2,925 $71K
70551 Magnetic resonance imaging, brain; without contrast material <1% 392 $68K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 4,574 $68K
83880 <1% 3,933 $68K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 2,177 $68K
93970 <1% 655 $66K
83690 <1% 13,057 $63K
81025 <1% 15,820 $60K
76801 <1% 1,325 $57K
0637 <1% 44,351 $53K
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,079 $53K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 3,823 $47K
0250 <1% 5,793 $43K
72100 <1% 1,472 $43K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 4,589 $42K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,721 $41K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,722 $41K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 916 $40K
76770 <1% 707 $40K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 3,257 $39K
0300 <1% 847 $38K
81002 <1% 20,765 $37K
72125 Computed tomography, cervical spine; without contrast material <1% 381 $36K
0272 <1% 10,993 $36K
J2270 Injection, morphine sulfate, up to 10 mg <1% 5,340 $36K
73030 <1% 1,529 $34K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,874 $33K
73610 <1% 1,539 $33K
73630 <1% 1,596 $31K
83605 <1% 4,298 $31K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 1,987 $29K
73562 <1% 1,222 $28K
87040 <1% 2,741 $27K
0270 <1% 4,892 $26K
73560 <1% 1,182 $26K
0258 <1% 7,525 $25K
80306 <1% 1,994 $24K
36415 Collection of venous blood by venipuncture <1% 13,736 $21K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 115 $21K
85610 <1% 8,352 $20K
81001 <1% 8,695 $20K
87086 Culture, bacterial; quantitative colony count, urine <1% 3,694 $18K
85730 <1% 4,770 $18K
84443 Thyroid stimulating hormone (TSH) <1% 2,364 $17K
84702 <1% 1,811 $16K
84145 <1% 1,198 $16K
87088 <1% 3,393 $15K
73130 <1% 735 $15K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 367 $15K
80053 Comprehensive metabolic panel <1% 3,739 $14K
87077 <1% 3,029 $14K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 2,145 $13K
82947 <1% 3,764 $13K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 300 $13K
73110 <1% 456 $12K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 247 $12K
87186 <1% 2,356 $12K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 207 $12K
85378 <1% 2,177 $12K
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 1,140 $11K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 78 $11K
78815 Positron emission tomography (PET) for limited area imaging <1% 24 $10K
77063 Screening digital breast tomosynthesis, bilateral <1% 684 $10K
0259 <1% 912 $10K
83735 <1% 2,625 $9K
72040 <1% 413 $9K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,842 $9K
73502 <1% 396 $9K
86140 <1% 2,605 $8K
0271 <1% 895 $8K
J2060 Injection, lorazepam, 2 mg <1% 1,546 $8K
86901 <1% 2,783 $7K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 367 $7K
0510 <1% 833 $7K
93296 <1% 1,279 $7K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 514 $5K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 70 $5K
86900 <1% 2,100 $5K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 384 $5K
82553 <1% 600 $5K
86850 <1% 1,309 $5K
80061 Lipid panel <1% 1,280 $4K
94664 <1% 610 $4K
82550 <1% 1,125 $4K
96367 <1% 164 $4K
90715 <1% 126 $4K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 72 $3K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 94 $3K
G0378 Hospital observation service, per hour <1% 13 $3K
93299 <1% 254 $3K
76642 <1% 95 $3K
97161 <1% 160 $3K
96376 <1% 588 $3K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 15 $3K
87430 <1% 350 $3K
A9270 Non-covered item or service <1% 536 $2K
73140 <1% 176 $2K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 215 $2K
96368 <1% 150 $2K
71100 <1% 142 $2K
76870 <1% 52 $2K
83036 Hemoglobin; glycosylated (A1C) <1% 996 $2K
70486 <1% 16 $2K
0320 <1% 106 $2K
0636 <1% 241 $2K
85652 <1% 951 $2K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 360 $2K
83615 <1% 373 $2K
74018 <1% 71 $2K
77080 <1% 97 $2K
80179 <1% 134 $1K
84439 <1% 604 $1K
80143 <1% 125 $1K
72141 <1% 12 $1K
73080 <1% 59 $1K
A0429 Emergency ambulance ride, basic life support <1% 64 $1K
76536 <1% 40 $1K
G2066 Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results <1% 152 $1K
84100 <1% 713 $1K
85027 <1% 610 $909.00
82077 <1% 110 $845.54
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 43 $805.73
0720 <1% 34 $805.13
71020 <1% 32 $730.38
J3370 Injection, vancomycin hcl, 500 mg <1% 29 $687.26
73590 <1% 44 $683.77
87210 <1% 225 $658.88
97535 Self-care/home management training, each 15 minutes <1% 106 $642.60
87581 <1% 26 $568.51
93880 <1% 14 $544.73
J1815 Injection, insulin, per 5 units <1% 87 $530.88
87486 <1% 26 $524.01
84550 <1% 478 $521.01
71010 <1% 35 $506.26
0710 <1% 53 $449.69
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 154 $437.08
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 13 $419.37
80320 <1% 173 $414.65
J3010 Injection, fentanyl citrate, 0.1 mg <1% 119 $311.06
0370 <1% 26 $292.34
72070 <1% 14 $279.45
J7050 Infusion, normal saline solution, 250 cc <1% 45 $278.71
72110 <1% 13 $271.68
Z7610 <1% 18 $265.37
73660 <1% 12 $190.92
74019 <1% 12 $161.69
10060 <1% 13 $134.85
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 20 $132.75
87070 <1% 28 $131.83
87205 <1% 44 $119.60
82728 <1% 187 $103.44
83550 <1% 166 $100.30
J2704 Injection, propofol, 10 mg <1% 13 $96.60
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 17 $83.10
87081 <1% 17 $80.04
83540 <1% 190 $79.71
82607 <1% 53 $72.75
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 17 $70.96
0760 <1% 15 $68.20
82746 <1% 55 $54.67
J7030 Infusion, normal saline solution , 1000 cc <1% 29 $50.78
82570 <1% 102 $36.94
84153 <1% 27 $18.02
82043 <1% 222 $16.40
84156 <1% 63 $13.78
J1630 Injection, haloperidol, up to 5 mg <1% 28 $12.92
85045 <1% 85 $7.48
83970 0% 52 $0.00
84481 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHALL, SHANIN (BUSINESS OFFICE MANAGER)